Sapacitabine

  • Catalog number
    B2002-25
  • Price
    Please ask
  • Size
    25 mg
  • Alternative_name
    N-(1-((2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)palmitamide; CS682; CYC682; CYC-682
  • Description
    Sapacitabine is an orally bioavailable nucleoside analog prodrug that is potentially useful for treatment of hematologic malignancies and solid tumors. The active metabolite of sapacitabine, CNDAC (2'-C-cyano-2'-deoxy-1-β-D-arabino-pentofuranosylcytosine), displays the unique mechanism of action of causing single-strand breaks (SSBs) after incorporation into DNA, which are converted into double-strand breaks (DSBs) when cells enter a second S-phase. 
  • CAS Number
    151823-14-2 
  • Structure Available
    Yes
  • Salt Form
    No
  • Molecular Formula
    C₂₆H₄₂N₄O₅ 
  • Molecular Weight
    490.64
  • Cell Permeable
    Yes
  • Purity
    ≥98% by HPLC
  • Solubilities
    DMSO
  • Handling
    Protect from air and light
  • Tag Line
    An anticancer agent
  • Storage Condition
    -20°C
  • Shipping Condition
    gel pack
  • Shelf Life
    36 months
  • PubChem CID
    153970
  • SMILES
    CCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)C2C(C(C(O2)CO)O)C#N
  • InChi
    InChI=1S/C26H42N4O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-23(32)28-22-16-17-30(26(34)29-22)25-20(18-27)24(33)21(19-31)35-25/h16-17,20-21,24-25,31,33H,2-15,19H2,1H3,(H,28,29,32,34)/t20-,21+,24-,25+/m0/s1
  • InChi Key
    LBGFKUUHOPIEMA-PEARBKPGSA-N
  • MSDS Available
    Yes
  • Gene target
  • Short name
    Sapacitabine
  • Alternative name
    Sapacitabine
Product images
Similar products
Filters
Contact
Chat with gentaur.com employee